Hollie Franklin, Author at Drugs in Context

Comparison of modafinil and pitolisant in narcolepsy: a non-inferiority metaanalytical approach

Philippe Lehert Dr Ir PhD, Cassandra Szoeke MD, GAICD, PhD, FRACP, AMA(M), MBBS

Article Type

Original Research

Published

08 Jul 2020

This research assesses the non-inferiority of pitolisant, a new compound for the relief of excessive daytime sleepiness and cataplexy in narcolepsy, compared with modafinil.

Urinary tract infections in the elderly: a review of disease characteristics and current treatment options

Leocadio Rodriguez-Mañas MD, PhD

Article Type

Review

Published

08 Jul 2020

This narrative review considers the characteristics of urinary tract infections – prevalence and incidence, disease burden, risk factors, and clinical presentation – in the elderly, and examines current treatment options to manage urinary tract infections in the community.

Kawasaki disease in siblings and a review of drug treatment

Steven King-fan Loo MBChB, FRCP, Kam Lun Hon MBBS, MD, FAAP, FCCM, Alexander KC Leung MBBS, FRCPC, FRCP (UK & Irel), FRCPCH, FAAP, Tak Cheung Yung MBBS, MRCPCH, Man Ching Yam MBChB, MRCPCH

Article Type

Case Report

Published

07 Jul 2020

This article describes the management of two siblings with KD
followed by a short review.

Reducing residual thrombotic risk in patients with peripheral artery disease: impact of the COMPASS trial

José Luis Hernández MD, PhD, Francisco S Lozano MD, PhD, Vincent Riambau MD, PhD, Manuel Almendro-Delia MD, PhD, Juan Cosín-Sales MD, PhD, Sergi Bellmunt-Montoya MD, PhD, Javier Garcia-Alegria MD, PhD, Xavier Garcia-Moll MD, FESC, FACC, Juan José Gomez-Doblas MD, PhD, José R Gonzalez-Juanatey MD, PhD, Carmen Suarez Fernández MD

Article Type

Review

Published

26 Jun 2020

In this narrative review, data about how to reduce residual risk through the best antithrombotic
approach among patients with peripheral artery disease, with a particular focus
on the COMPASS trial, are updated in order to provide some
practical recommendations about its use in this population.

Coronavirus disease 2019 (COVID-19): latest developments in potential treatments

Kam Lun Hon MBBS, MD, Karen Ka Yan Leung MBBS, MRCPCH, Alexander KC Leung MBBS, FRCPC, FRCP (UK & Irel), FRCPCH, FAAP, Su Yun Qian MD, Vivian PY Chan MPharm, MSc (Clin Pharm), BPharm, BCPPS, BCNSP, Patrick Ip MBBS, FRCPCH (Hon), FRCPCH, Ian CK Wong BPharm (Hons), MSc, PhD, FRCPCH (Hon)

Article Type

Review

Published

29 Jun 2020

This overview aims to review the current developments in preventive treatments and therapies for COVID-19.